Viewing Study NCT06364904


Ignite Creation Date: 2025-12-24 @ 9:19 PM
Ignite Modification Date: 2026-06-24 @ 6:59 AM
Study NCT ID: NCT06364904
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-02-21
First Post: 2024-04-10
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Clinical Trail to Determine the Safety and Efficacy of the Combination of Tislelizumab With Cisplatin and Gemcitabine, With or Without Trilaciclib for Patients With Untreated Unresectable and Metastatic Urothelial Carcinoma.
Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Bladder Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Immune Checkpoint Inhibitor View
None CDK4/6 Inhibitor View
None Cisplatin View
None Tislelizumab View
None Gemcitabine View
None Trilaciclib View